# COMAR Title 10 — Maryland Department of Health

## Subtitle 47 — Alcohol and Drug Abuse Administration

### Chapter 07 — Prescription Drug Monitoring Program

#### Regulation .04 Review of Prescription Monitoring Data.

*COMAR 10.47.07.04*

A. The Program shall review prescription monitoring data and naloxone medication data for indications of possible:

  (1) Misuse or abuse of a monitored prescription drug; and

  (2) Violations of law or possible breaches of professional standards by a prescriber or a dispenser.

B. In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.